Submitted by Anonymous (not verified) on 27 March 2025 - 16:25
Human medicines European public assessment report (EPAR): Respreeza, alpha1-proteinase inhibitor (human), Date of authorisation: 20/08/2015, Revision: 15, Status: Authorised
Source: